Delivery Order SPE2DB20D1109-SPE2DB23FN04B
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,100.81 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for Lidocaine 5% patches valued at $1,356.31. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to the U.S. military and veterans' healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,263.40 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA) and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $5,885.44 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine 5% Patches over a 2-year period ending in March 2024. The $2,531.78 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,080.96 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has an ultimate completion date of April 6, 2023. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract, valued at $4,561.79, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (DO) valued at $7,363.60 for the supply of Lidocaine 5% Patches. The contract is issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,221.70 firm-fixed-price delivery order is for the supply of Lidocaine 5% Patches to support military and government medical requirements. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of 4,559,047,498 units of Lidocaine 5% Patch 30s. The contract, valued at $2,299.32, is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN04BDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,507.88 for the supply of Lidocaine 5% Patches. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen Drug Corp's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/21/22 |